BioSenic S.A. (BIOS.BR)
EUR 0.01
(-5.71%)
EUR 0.01
(-5.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.49 Million | -1.91 Million | -12.78 Million | -16.08 Million | -10.4 Million | -12.9 Million |
| Net Income | -28.77 Million | -2.31 Million | -12.02 Million | -17.44 Million | -9.57 Million | -11.46 Million |
| Depreciation & Amortization | 234 Thousand | 60 Thousand | 186 Thousand | 601 Thousand | 753 Thousand | 580 Thousand |
| Deferred income taxes | - | - | 1.78 Million | 2.23 Million | 3.25 Million | 1.7 Million |
| Stock-based compensation | - | - | -99 Thousand | 266 Thousand | -472 Thousand | 52 Thousand |
| Change in working capital | 1.68 Million | 219 Thousand | -1.3 Million | 709 Thousand | -188 Thousand | -405 Thousand |
| Other non-cash items | 22.13 Million | 129 Thousand | -1.31 Million | -2.44 Million | -4.16 Million | -3.36 Million |
| Investing Cash Flow | 6000.00 | 1.95 Million | -204 Thousand | 11.9 Million | -302 Thousand | -295 Thousand |
| Investments in PPE | 3.49 Million | -5000.00 | -207 Thousand | -93 Thousand | -310 Thousand | -296 Thousand |
| Acquisitions | 6000.00 | 1.95 Million | - | 12 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6000.00 | 1000.00 | 3000.00 | 2000.00 | 8000.00 | 1000.00 |
| Financing Cash Flow | 1.76 Million | 1.04 Million | 7.85 Million | 10.18 Million | 11.16 Million | 12.95 Million |
| Debt repayment | -725 Thousand | -424 Thousand | -2.54 Million | -6.61 Million | -986 Thousand | -823 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.5 Million | -22 Thousand | 3.28 Million | 11.79 Million | 8.52 Million | 13.51 Million |
| Other Financing Activities | -276 Thousand | 1.49 Million | 7.11 Million | 5 Million | 3.62 Million | 269 Thousand |
| Accounts receivables | 55 Thousand | 44 Thousand | 10 Thousand | -1.01 Million | -5000.00 | -810 Thousand |
| Accounts payables | 1.63 Million | 175 Thousand | -187 Thousand | 1.72 Million | -183 Thousand | 405 Thousand |
| Inventory | - | - | - | -2.31 Million | -3.28 Million | - |
| Other working capital | 1.63 Million | - | -1.13 Million | 2.31 Million | 3.28 Million | 1.83 Million |
| Cash at beginning of period | 1.84 Million | 759 Thousand | 14.64 Million | 8.63 Million | 8.17 Million | 8.41 Million |
| Cash at end of period | 117 Thousand | 1.84 Million | 9.51 Million | 14.64 Million | 8.63 Million | 8.17 Million |
| Capital Expenditure | 3.49 Million | -5000.00 | -207 Thousand | -93 Thousand | -310 Thousand | -296 Thousand |
| Effect of forex changes on cash | - | - | - | 1000.00 | -1000.00 | 1000.00 |
| Net cash flow / Change in cash | -1.72 Million | 1.08 Million | -5.13 Million | 6.01 Million | 459 Thousand | -237 Thousand |
| Free Cash Flow | - | -1.91 Million | -12.99 Million | -16.17 Million | -10.71 Million | -13.19 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 247.5 Thousand | 247.5 Thousand | -28.77 Million | -3.96 Million | -3.96 Million | -20.84 Million |
| Depreciation & Amortization | 53 Thousand | 53 Thousand | 234 Thousand | 71 Thousand | 71 Thousand | 101 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | -31.5 Thousand | -31.5 Thousand | - | - | - | - |
| Change in working capital | -62.5 Thousand | -62.5 Thousand | 1.68 Million | 44.5 Thousand | 44.5 Thousand | 458 Thousand |
| Other non-cash items | -623.5 Thousand | -623.5 Thousand | 22.13 Million | 3.08 Million | 3.08 Million | 18.08 Million |
| Investing Cash Flow | - | - | 6000.00 | -500.00 | -500.00 | 7000.00 |
| Investments in PPE | - | - | - | 6000.00 | 6000.00 | -13 Thousand |
| Acquisitions | - | - | 6000.00 | 3000.00 | - | 3000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 6000.00 | -6500.00 | -6500.00 | 17 Thousand |
| Financing Cash Flow | 766.5 Thousand | 766.5 Thousand | 1.76 Million | 569.5 Thousand | 569.5 Thousand | 609 Thousand |
| Debt repayment | -953 Thousand | - | -725 Thousand | -400 Thousand | - | -325 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 500 Thousand | - | 1.5 Million | 1.05 Million | - | 450 Thousand |
| Other Financing Activities | 766.5 Thousand | 766.5 Thousand | -276 Thousand | 569.5 Thousand | 569.5 Thousand | -82 Thousand |
| Accounts receivables | -62.5 Thousand | -62.5 Thousand | 55 Thousand | 44.5 Thousand | 44.5 Thousand | -34 Thousand |
| Accounts payables | -827 Thousand | - | 1.63 Million | 1.14 Million | - | 492 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 117 Thousand | - | 1.84 Million | 519 Thousand | - | 3.96 Million |
| Cash at end of period | 816 Thousand | 349.5 Thousand | 117 Thousand | 117 Thousand | -201 Thousand | 519 Thousand |
| Capital Expenditure | - | - | - | 6000.00 | 6000.00 | -13 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | -2.11 Million |
| Net cash flow / Change in cash | 699 Thousand | 349.5 Thousand | -1.72 Million | -402 Thousand | -201 Thousand | -3.44 Million |
| Free Cash Flow | -417 Thousand | -417 Thousand | -3.49 Million | -764 Thousand | -764 Thousand | -1.95 Million |
ELDN
EASTW-R
PKST
002382
ACUS
MDP